• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Small Innovators & Niche CROs

    Focus on Science

    Rapid and Data Rich Chromatographic Method Development

    Preparing Your Post Pandemic Talent Strategy

    How Modern Near-Infrared Came to Be
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Resilience Acquires Ology Bioservices

    RDIF, Hualan Ink COVID-19 Vaccine Deal

    Kintor, Visum Enter COVID-19 Manufacturing Partnership

    Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

    Evotec Enters Master Service Agreement with Kazia Therapeutics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Abenza Chooses North Carolina for New Biologics Manufacturing Site

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Recro, Ensysce Expand Development and Manufacturing Partnership

    Metrics Names Stephanie Emory Associate Director of Pharma Development

    Albumedix Completes Commercial-Scale Mfg. Facility Expansion
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Obituary Notice: Russell “Russ” Haines

    Catalent Adds Cryogenic Capabilities at Philadelphia Facility

    Cryoport Acquires Critical Transport Solutions Australia

    PharmParts – This Makes Sense!

    Securing Your API Supply Chain: Three Keys to Success
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Resilience Acquires Ology Bioservices

    RDIF, Hualan Ink COVID-19 Vaccine Deal

    Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU

    Evotec Enters Master Service Agreement with Kazia Therapeutics

    Bristol Myers Squibb Expands at Cambridge Crossing
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Ensuring Pharma Manufacturing Quality

    What Will Change at FDA for 2021?

    RBQM Comes of Age: COVID as a Catalyst for Change

    Post-Pandemic Regulations

    Enteris BioPharma: Custom Solutions – From Bench to Market
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Reed-Lane

    Alcami

    Almac Group

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Quotient Sciences

    PCI Pharma Services

    Adare Pharma Solutions

    Alcami

    Syngene
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Back Page

    Virtual Trials: Are they living up to their hype?

    This innovative approach is less costly, more patient-friendly, and delivers better quality data however, many stakeholders are still uncertain

    Virtual Trials: Are they living up to their hype?
    Related CONTENT
    • Eisai, Biogen Discontinue Phase III Alzheimer's Trials
    • FDA Extends CRADA with CluePoints
    • Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies
    • Caladrius, Cognate Ink Clinical Manufacturing Agreement
    • Virtual Trials: Are they living up to their hype?
    Josh Rose, VP R&D Global Strategy and Head of Virtual Trial Solutions, IQVIA09.16.19
    We’ve been talking about the value of virtual trials for a few years now. Are they delivering on their promise? The benefits are uncontestable—this innovative approach to clinical research is less costly, more patient-friendly, easier to recruit and delivers better quality data than a traditional site-based trial. However, many stakeholders are still uncertain about whether this trial model will work for them.

    Virtual trials are still relatively new, and in a highly regulated, risk-averse environment, embracing change can be difficult. But the truth is that virtual trials have been supported by regulators and proven to work in many scenarios, which should give stakeholders the confidence they need to get started.

    Lessons learned
    Executing virtual trials is complicated. This isn’t meant to discourage their use but to set appropriate expectations. Clinical trials by their nature are complex, and implementing virtual trials requires much more than simply deploying telemedicine services or giving patients a mobile app. They involve multiple platforms and devices, each of which captures and/or manages a unique data set that will follow its own cadence and construct. All of these platforms and workflows need to be seamlessly integrated and customized to accommodate the idiosyncrasies of that trial’s protocols, patient abilities and investigator needs. The personnel and patients involved in the trial also require training to use these tools while adhering to all rules and industry regulations.

    When vetting partners, sponsors should be certain their vendors have enough industry, technological and regulatory expertise to create a virtual trial environment that addresses all of these needs.

    Most virtual trials will follow a hybrid model. While a pure, 100 percent virtual trial is the ideal state from a cost-savings and efficiency standpoint, most trials have some on-site visits that can’t be fully eliminated. That’s OK. A hybrid model, which combines some site visits with virtual elements, still delivers time and cost savings while improving the patient experience and gives sponsors a low-risk jumping off point to become familiar with the virtual trial environment.

    By 2022, up to 40 percent of new trials may have some (or all) virtual elements, including telemedicine, home health visits and online surveys and questionnaires. By starting small and vetting the validity and reliability of existing virtual technologies, sponsors can gain confidence that future virtual deployments will deliver all of the promised results.

    Start early and make “virtual” part of the protocol planning. A virtual trial is about more than just selecting technology. It requires a different way of thinking about how investigators will engage with patients, collect data and demonstrate safety. By making it part of the trial planning process, sponsors ask the right questions from the outset, like how many physicals are really needed, whether endpoint data can be captured at home and whether wearable devices, telemedicine and home health nurses can replace on-site visits. When sponsors wait until after the trial protocol is approved to consider a virtual model option, many of these decisions have to be revisited, which adds costly delays to the process.

    Executive sponsorship is key. No matter how much the research team wants to test a virtual trial environment, until executive leadership is on-board, it won’t happen. They make the financial decisions, and they decide how much risk the organization is willing to take. Without their vocal support, others in the organization will be reluctant to engage in a new and unproven clinical research method. The good news is that once they are on-board, experience shows that these trials ramp up quickly, and that these leaders take an active role in engaging with regulators and working with CROs to ensure the deployment is a success.

    You need goals that are measurable and meaningful. As with any change-management effort, the only reason to do it is if it will solve a specific business problem or generate better results. There are many business and clinical benefits associated with virtual trials that can be easily measured, including accelerated recruiting, reduced costs and attrition, improved patient engagement and increased quality and quantity of data. All of these benefits help speed drug development and improve revenues. When you begin this journey with a business goal in mind, it becomes easier to win over executives and demonstrate the impact of this transformational approach to research.

    No two virtual trials are ever the same. Every clinical trial is unique, whether it’s conducted entirely through on-site visits, in a purely virtual format or somewhere in between. And while every virtual trial will provide sponsors with valuable insights into how to operate in the virtual environment, each new trial design will require a customized, strategic approach. The key is to keep an open mind, to capture lessons learned from the past and to work with partners who have deep technical, clinical and regulatory knowledge to ensure every trial meets the highest expectations for safety, quality, compliance and financial results. 
    Related Searches
    • Development
    • clinical research
    • training
    • Clinical Trial
    Suggested For You
    Eisai, Biogen Discontinue Phase III Alzheimer Eisai, Biogen Discontinue Phase III Alzheimer's Trials
    FDA Extends CRADA with CluePoints FDA Extends CRADA with CluePoints
    Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies  Embracing Risk-Based Monitoring: The Pivotal Role of Tools and Technologies
    Caladrius, Cognate Ink Clinical Manufacturing Agreement Caladrius, Cognate Ink Clinical Manufacturing Agreement
    Virtual Trials: Are they living up to their hype? Virtual Trials: Are they living up to their hype?
    14	Bayer 14 Bayer
    05	Sanofi 05 Sanofi
    02	Novartis 02 Novartis
    CDMO Great Bay Bio Founded CDMO Great Bay Bio Founded
    Eisai Inc. Adds Expert Alzheimer Eisai Inc. Adds Expert Alzheimer's Executives
    Pushing Research to Its Full Potential Pushing Research to Its Full Potential
    Evolution Research Acquires Finger Lakes Clinical Research Evolution Research Acquires Finger Lakes Clinical Research
    LabConnect Appoints Medical Director LabConnect Appoints Medical Director

    Related Back Page

    • Information Technology
      Data Management in Life Sciences: Then and Now

      Data Management in Life Sciences: Then and Now

      A look at landmark changes in the management of data in the life sciences over the last 20 years and how the industry has addressed the challenges these develop
      Jason Lacombe, CEO, Veratrak 10.15.19

    • Biologics, Proteins, Vaccines | Clinical Trials
      Getting to First-in-Human Clinical Trials

      Getting to First-in-Human Clinical Trials

      A make-or-break milestone for small biopharmas
      David Kenyon, Patheon 10.10.18

    • Clinical Trials

      CRO Revenues Are Being Jeopardized By Calls Not Connecting

      CRO revenues are being jeopardized
      Stephen Levenson, Global Telecom Testing 06.02.16


    • Clinical Trials

      Door-to-door Service and Telemedicine

      How innovative approaches are changing the way patients are recruited into rare disease trials
      Cynthia Jackson, Pediatric Center of Excellence 05.05.16

    • Clinical Trials | Drug Development | Supply Chain

      Investing in Big Data-Driven Risk-Based Monitoring

      Benefits of Big Data include managing risk and improving operational efficiency
      Kyle Given, Medidata 05.06.15

    • Clinical Trials | Validation

      Where is the “Quality” in GCP?

      Collaboration is key in conducting successful clinical trials
      Suzanne Tran, Technical Resources International 04.01.15


    • Clinical Trials | Drug Development

      Five Predictions for 2015

      What’s next for clinical data management and investments?
      Rick Morrison, Comprehend Systems 01.29.15

    • Clinical Trials | Drug Development

      Generic Company CEOs: 505(b)(2)

      Development strategy to drive growth
      Ken Phelps, Camargo Pharmaceutical Services 04.03.14

    • Clinical Trials | Drug Development

      The Power of the Cloud

      ...
      Rick Morrison, Comprehend Systems 03.07.14


    • Clinical Trials | GMPs/GCPs | Inspections | Regulatory Affairs

      Orphan Drugs

      Increasing reimbursement and commercialization barriers
      Anthony Harrington, Results Healthcare 11.13.13

    • Aseptic Processing | Cleaning Validation | Clinical Trials | Extractables and Leachables | Facilities | GMPs/GCPs | Inspections | Methods Development | Microbiology | Parenterals | Process Development | QA/QC | Validation

      The Next Generation CMOs

      Aseptic processing designs must advance
      Jason S. Collins, IPS-Integrated Project Services 10.09.13

    Trending
    • Jubilant, Novavax Enter COVID-19 Vaccine Partnership
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement With EU
    • Resilience Acquires Ology Bioservices
    • Ensuring Pharma Manufacturing Quality
    • Sartorius Expands In The UK
    Breaking News
    • Resilience Acquires Ology Bioservices
    • RDIF, Hualan Ink COVID-19 Vaccine Deal
    • Kintor, Visum Enter COVID-19 Manufacturing Partnership
    • Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU
    • Evotec Enters Master Service Agreement with Kazia Therapeutics
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Small Innovators & Niche CROs
    • Focus on Science
    • Rapid and Data Rich Chromatographic Method Development
    • Preparing Your Post Pandemic Talent Strategy
    • How Modern Near-Infrared Came to Be
    • Securing Your API Supply Chain: Three Keys to Success
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Review Concludes That Refined Grains Have a Place in Healthy Eating Patterns
    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    SOS '21 Call For Papers
    ICP Acquiring Choice Adhesives
    PPG Brand Olympic Stains Announces 1st Ever 2021 Stain Color of the Year
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Canon Medical's One-Beat Spectral Cardiac CT
    NeuroLogica Debuts Next-Generation SmartMSU with OmniTom Elite
    IZI Medical Products Launches Fully Automatic Quick-Core Auto Biopsy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Resilience Acquires Ology Bioservices
    RDIF, Hualan Ink COVID-19 Vaccine Deal
    Kintor, Visum Enter COVID-19 Manufacturing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    2021 Perfumed Plume Awards Announces Finalists
    Bésame Cosmetics Unveils Marilyn Monroe Collection
    Procos Opens U.S. Office
    Happi

    Latest Breaking News From Happi

    Hair Luxury Company Expands Availability of Its Vegan Beauty to Walmart Online
    ACI Appoints Director, State Government Affairs
    Jergens Launches Mother’s Day Campaign
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Sakata INX and INX International continue sustainability efforts
    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Andritz to Supply Elliptical Cylinder Pre-Needler in France
    Ahlstrom-Munksjö to be Delisted from Nasdaq Stockholm
    Radienz Living Introduces Sustainable Products
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AgNovos Healthcare's AGN1 LOEP SV Kit Obtains IDE
    First Surgeries Completed with Globus Medical's CREO ONE Robotic Screw
    BioMagnetic Sciences Names President and CEO
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    SEMI, Center for Automotive Research Collaborate
    Zebra Technologies Introduces New Alliance Track for PartnerConnect Channel Program
    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login